Research factsheet14 October 2026
Download PDF
PRVXLONPorvair PLC
CME, new financial framework and trading update · RNS 8203Y · 14 October 2026

Porvair sets 16–18% margin target for FY31 as trading runs slightly ahead

Share price830p
Market cap£387m
52-week range678.8p – 920p
Shares in issue46.6m
12-month change+8.4%
Ticker Data API, as at 20 Nov 2026, 16:29

Share price, 12 months

700p800p900p Announcement, 14 October 2026Nov 25Jan 26Mar 26May 26Jul 26Sept 26Nov 26

Summary

Porvair used today's Capital Markets Event to set a new medium-term framework: total revenue growth of 10%+, mid-single-digit organic growth, adjusted operating margins of 16–18% by FY31 and adjusted EPS growth of 10–20%. Alongside it, a ten-month trading update to 30 September showed organic revenue growth in all three divisions, an adjusted operating margin slightly ahead of the prior period and a modest net cash position excluding leases after three acquisitions. The Board expects the full year to come in slightly ahead of market expectations, which repeats the outlook given on 22 September without extending it. The targets sit well above recent delivery: the adjusted margin was 13% in the first half, and nine-month organic growth was 5%. The framework is new, and the evidence that it can be met will come with the year-end figures.

Key figures

FigureValuePeriodChange
Adjusted operating margin target16 – 18%FY31
Adjusted EPS growth target10 – 20%Medium term
Total revenue growth target10%+Medium term
Return on invested capital target18%+Medium term
Constant currency revenue growth14%Nine months to 31 Aug 20265% organic constant currency
Adjusted operating margin13%H1 FY26prior 12.9%
Adjusted return on capital employed14%H1 FY26prior 13.8%
Cash generated from operations£9.70mH1 FY26prior £10.2m
Operating cash flow£23.8mYear to 30 Nov 2025against profit after tax of £18.2m
G.G.G. S.p.A holding29.00%Threshold crossed 22 Apr 2026from 28.05%
Sources: CME, new financial framework and trading update RNS, 14 Oct 2026; Nine Month Trading Update RNS, 22 Sep 2026; Interim Results RNS, 29 Jun 2026; Annual Report & Accounts 2025, primary statements; Holding(s) in Company RNS, 24 Apr 2026

The announcement

Against guidance

The near-term message has firmed through the year. In December 2025 the company pointed to adjusted EPS marginally ahead of market expectations. In April 2026 it said trading was in line, and on 22 September it moved to full-year trading slightly ahead of expectations. Today's update reaffirms slightly ahead, with organic growth in every division and a margin slightly above the prior period, but gives no number, so it confirms the September upgrade and adds no second one. The medium-term framework is new and has no prior guidance to compare with. Its 16–18% margin target is three to five points above the 13% adjusted margin of the first half, and the 18%+ ROIC target uses a different measure from the 14% adjusted ROCE reported at the interims.

Bull case

  • The record supports trust in near-term guidance: operating profit rose every year on file, from £19.8m in FY2022 to £24.5m in FY2025, and the 2026 outlook has moved from in line to slightly ahead.
  • Cash has backed up profit. FY2025 operating cash flow of £23.8m exceeded profit after tax of £18.2m, and the group stayed modestly net cash excluding leases after buying Drache (€20.5m), Carekem (£1.1m) and GV Filtri (€6.7m), so further bolt-ons can be funded without stretching the balance sheet.
  • The register adds a corporate-event option: G.G.G. S.p.A holds 29.00%, Long Path Partners about 12%, and ShareCast reported in May that activist Richard Bernstein was calling for a sale. This is a possibility, not something the numbers can underwrite.

Bear case

  • The targets outrun recent delivery. Nine-month organic growth was 5%, so the 10%+ total revenue target depends on acquisitions, and the H1 adjusted margin edged up only to 13% from 12.9% while the statutory margin slipped.
  • Cash conversion is untested on the new basis: H1 cash generated from operations fell to £9.70m from £10.2m while adjusted operating profit rose to £13.8m from £12.6m, and the 85%+ measure is not defined in the announcement. Net cash is also stated excluding leases, which stood at £29.9m at November 2024.
  • The backdrop is less friendly to paying up for a UK small-cap: the 10-year gilt yield was 5.75% on 9 October, up 0.37 points in three months, and Brent was $104.73 on 13 October, up 23.3%, adding to input-cost risk.

What to watch

This research is produced by Ticker using automated analysis of company announcements, filings and market data. It is for information only, is not personal advice or a recommendation to buy or sell any security, and may contain errors. Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise. Market data from Ticker's Data API as at 20 Nov 2026, 16:29.